Allegis Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$915K Sell
4,432
-1,735
-28% -$364K 0.28% 77
2017
Q4
$1.17M Sell
6,167
-433
-7% -$83K 0.35% 83
2017
Q3
$1.25M Sell
6,600
-1,004
-13% -$182K 0.3% 90
2017
Q2
$1.33M Buy
7,604
+887
+13% +$149K 0.34% 89
2017
Q1
$1.03M Buy
6,717
+428
+7% +$65.4K 0.27% 90
2016
Q4
$887K Buy
6,289
+739
+13% +$109K 0.28% 100
2016
Q3
$883K Buy
5,550
+328
+6% +$50.5K 0.34% 95
2016
Q2
$758K Buy
5,222
+691
+15% +$102K 0.38% 86
2016
Q1
$642K Buy
4,531
+794
+21% +$106K 0.37% 94
2015
Q4
$530K Buy
+3,737
New +$498K 0.3% 97

Other funds holding TMO

Allegis Investment Advisors's TMO Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q1 2018, selling an estimated $364K and leaving 4,432 shares worth $915K. The position accounts for 0.28% of the portfolio, ranked #77.

Allegis Investment Advisors first reported a position in TMO in Q4 2015 and has held it in 10 quarters since. The position peaked at $1.33M in Q2 2017. 1,306 funds tracked by Wall St. Rank hold TMO as of Q1 2018.

  • Allegis Investment Advisors held 4,432 shares of Thermo Fisher Scientific worth $915K as of Q1 2018.
  • Allegis Investment Advisors sold 1,735 Thermo Fisher Scientific shares in Q1 2018, an estimated $364K.
  • Thermo Fisher Scientific made up 0.28% of Allegis Investment Advisors's portfolio in Q1 2018, its #77 holding.
  • Allegis Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 10 quarters since.
  • Allegis Investment Advisors's Thermo Fisher Scientific position peaked at $1.33M in Q2 2017.
  • 1,306 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.